Who are VASCULAR BIOSCIENCES, INC.'s investors?

VASCULAR BIOSCIENCES, INC.'s investors include Department of Health and Human Services.

When was VASCULAR BIOSCIENCES, INC. founded?

VASCULAR BIOSCIENCES, INC. was founded in 2017.

Where is VASCULAR BIOSCIENCES, INC. headquartered?

VASCULAR BIOSCIENCES, INC. is headquartered in DURHAM, North Carolina, United States.

What industry is VASCULAR BIOSCIENCES, INC. in?

VASCULAR BIOSCIENCES, INC. operates in Biotech, Healthcare, Medical Devices.

How many employees does VASCULAR BIOSCIENCES, INC. have?

VASCULAR BIOSCIENCES, INC. has 1-10 employees.

VASCULAR BIOSCIENCES, INC.

Next-generation targeted solutions for cardiovascular disease.

DURHAM, United States · Founded 2017

Biotech

Healthcare

Medical Devices

Headquarters: DURHAM, North Carolina
Employees: 1–10
Founded: 2017
Business Model: B2B

Website: vascularbiosciences.com
Last Round: GrantJan 2017
Rounds: 1

About

Vascular BioSciences is a biopharmaceutical and medical device company developing targeted therapies, interventional devices, and molecular diagnostics for cardiovascular and inflammatory diseases. Its lead CAR peptide candidate selectively homes to diseased tissue to enhance gene therapy and drug efficacy. The company pioneered the world's first endoarterial biopsy method enabling non-surgical vascular disease diagnostics.

Summary

VASCULAR BIOSCIENCES, INC. is a Biotech company based in DURHAM, United States, founded in 2017. Its most recent funding was a Grant round in Jan 2017. Investors include Department of Health and Human Services.